ŞAHİN, T. K. Et Al. 2024. Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine. PHARMACEUTICALS , no.7 .

ŞAHİN, T. K., AKYILDIZ, A., DOĞAN, O. T., KAVGACI, G., GÜVEN, D. C., & AKSOY, S., (2024). Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine. PHARMACEUTICALS , no.7.

ŞAHİN, TAHA Et Al. "Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine," PHARMACEUTICALS , no.7, 2024

ŞAHİN, TAHA K. Et Al. "Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine." PHARMACEUTICALS , no.7, 2024

ŞAHİN, T. K. Et Al. (2024) . "Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine." PHARMACEUTICALS , no.7.

@article{article, author={TAHA KORAY ŞAHİN Et Al. }, title={Prognostic Significance of Pan-Immune-Inflammation Value in Patients with HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine}, journal={PHARMACEUTICALS}, year=2024}